Gene: ME1
Official Full Name: malic enzyme 1provided by HGNC
Gene Summary: This gene encodes a cytosolic, NADP-dependent enzyme that generates NADPH for fatty acid biosynthesis. The activity of this enzyme, the reversible oxidative decarboxylation of malate, links the glycolytic and citric acid cycles. The regulation of expression for this gene is complex. Increased expression can result from elevated levels of thyroid hormones or by higher proportions of carbohydrates in the diet. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36683 | ME1 Knockout cell line (HeLa) | Human | ME1 | 1:3~1:6 | Negative | Online Inquiry |
KO36684 | ME1 Knockout cell line (HCT 116) | Human | ME1 | 1:2~1:4 | Negative | Online Inquiry |
KO36685 | ME1 Knockout cell line (HEK293) | Human | ME1 | 1:3~1:6 | Negative | Online Inquiry |
KO36686 | ME1 Knockout cell line (A549) | Human | ME1 | 1:3~1:4 | Negative | Online Inquiry |
ME1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the ME1 gene, which encodes the enzyme malic enzyme 1, pivotal in metabolic pathways involving NADPH and pyruvate production. These knockout cell lines serve as a critical tool in studying cellular energy metabolism, signaling pathways, and disease states, particularly in cancer research where metabolic dysregulation is a hallmark.
These cell lines operate by utilizing CRISPR-Cas9 technology, which facilitates precise gene editing, allowing researchers to observe the effects of gene loss on cellular behavior, growth dynamics, and metabolic shifts. By examining the resulting phenotypic changes, scientists can elucidate the role of ME1 in various biological processes, such as oxidative stress responses and fatty acid metabolism. This mechanism of action emphasizes the utility of ME1 knockout models in dissecting metabolic pathways and identifying potential therapeutic targets.
The scientific significance of ME1 Gene Knockout Cell Lines is underscored by their applications in both research and clinical settings. Researchers utilize these cell lines to explore the underlying mechanisms of metabolic diseases, develop new cancer therapies, and investigate the modulation of metabolic pathways in response to pharmacological agents. The ability to observe and manipulate these cellular systems provides valuable insights that are essential for advancing biomedical research.
Compared to traditional methods of analyzing gene function, our ME1 Gene Knockout Cell Lines offer a distinct advantage of precision and reproducibility. This specificity significantly reduces the variability often associated with other gene disruption techniques, ensuring that researchers obtain reliable and actionable data. Furthermore, our cell lines are validated for consistent performance, making them a dependable choice for rigorous experimental designs.
For researchers, clinicians, and pharmaceutical companies aiming to pioneer innovations in metabolic research, ME1 Gene Knockout Cell Lines represent a significant advancement in the toolkit of modern biology. With a proven track record of excellence in genetic engineering and cell line production, our company stands at the forefront of providing high-quality biological products designed to meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.